Filing Details

Accession Number:
0000899243-19-021636
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-13 16:05:41
Reporting Period:
2019-08-12
Accepted Time:
2019-08-13 16:05:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1666071 Cardlytics Inc. CDLX () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419148 Canaan Viii Lp C/O Canaan Partners
285 Riverside Avenue, Suite 250
Westport CT 06880
Yes No No No
1552200 Canaan Partners Viii Llc C/O Canaan Partners
285 Riverside Avenue, Suite 250
Westport CT 06880
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-12 84,185 $31.80 103,498 No 4 S Direct
Common Stock Disposition 2019-08-12 2,600 $33.11 100,898 No 4 S Direct
Common Stock Disposition 2019-08-12 100,898 $32.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.75 - $32.185, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The shares are held directly by Canaan VIII L.P. (the "Canaan Fund"). Canaan Partners VIII LLC ("Canaan VIII") is the sole general partner of the Canaan Fund, and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. John Balen is a manager and member of Canaan VIII. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan VIII, collectively. Canaan VIII disclaims Section 16 beneficial ownership of the shares held by the Canaan Fund, except to the extent, if any, of its pecuniary interest therein.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 - $33.21, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.75 - $32.50, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.